This is the protocol for a review and there is no abstract. The objectives are as follows:
The objectives of this review will be to assess the effectiveness and safety of ERT with laronidase in the management of patients with:
MPS I who do not undergo HSCT;
MPS I who receive ERT prior to HSCT.